CLYM
Climb Bio
CLYM
CLYM
47 hedge funds and large institutions have $355M invested in Climb Bio in 2024 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
106.63% more ownership
Funds ownership: 61.14% → 167.76% (+107%)
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
Holders
47
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$130M | |
| 2 | +$27.8M | |
| 3 | +$23.2M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$23.1M |
| 5 |
BC
Boxer Capital
San Diego,
California
|
+$18.5M |
Top Sellers
| 1 | -$6.01M | |
| 2 | -$822K | |
| 3 | -$214K | |
| 4 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$80.7K |
| 5 |
Millennium Management
New York
|
-$61.9K |